SCHEMBL7744060

SCHEMBL7744060

CCN1C[C@@H](CF)CC1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PER2 O15055 2/20 0.37
BRD4 O60885 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
P2RX7 Q99572 2/20 0.33
POLB P06746 3/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.32
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
APEX1 P27695 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2034969 1.00 PER2 (0.37) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL2031062 0.86 BRD4 (0.42) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL2034405 0.83 BRD4 (0.35) PER2BRD4POLBAPEX1BLM
SCHEMBL10274588 0.83 PER2 (0.42) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL3447557 0.80 BPTF (0.41) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL12002358 0.80 BRD4 (0.43) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL2034220 0.79 PER2 (0.35) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL13093555 0.78 BRD4 (0.36) PER2BRD4SMN1; SMN2KDM4EL3MBTL1
SCHEMBL8364335 0.78 PER2 (0.34) PER2BRD4APEX1BLM
SCHEMBL18922761 0.77 ALDH1A1 (0.43) PER2BRD4SMN1; SMN2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420818-B2 Process for the preparation of pyrido[2,1-a] isoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-04-16 US disclosed
US-20120035368-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES ABRECHT STEFAN (CH) 2012-02-09 US disclosed
US-20090163718-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163718-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES DPP4, DPP7, DPP3 PER2 3210/4885BRD4 884/4885SMN1; SMN2 2704/4885
US-20120035368-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES DPP4, DPP7, DPP3 PER2 3210/4885BRD4 884/4885SMN1; SMN2 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.